<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2019-5-4-0-3</article-id><article-id pub-id-type="publisher-id">1835</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title>Effect of &lt;em&gt;IL10&lt;/em&gt; (rs1800872) and &lt;em&gt;CXCL10&lt;/em&gt; (rs4386624, rs4256246) genes polymorphism in the development of viral and bacterial infectious diseases</article-title><trans-title-group xml:lang="en"><trans-title>Effect of &lt;em&gt;IL10&lt;/em&gt; (rs1800872) and &lt;em&gt;CXCL10&lt;/em&gt; (rs4386624, rs4256246) genes polymorphism in the development of viral and bacterial infectious diseases</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Goncharova</surname><given-names>Irina A.</given-names></name><name xml:lang="en"><surname>Goncharova</surname><given-names>Irina A.</given-names></name></name-alternatives><email>irina.goncharova@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Bragina</surname><given-names>Elena Yu.</given-names></name><name xml:lang="en"><surname>Bragina</surname><given-names>Elena Yu.</given-names></name></name-alternatives><email>elena.bragina@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Zhalsanova</surname><given-names>Irina Z.</given-names></name><name xml:lang="en"><surname>Zhalsanova</surname><given-names>Irina Z.</given-names></name></name-alternatives><email>irina.zhalsanova@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Babushkina</surname><given-names>Nadezhda P.</given-names></name><name xml:lang="en"><surname>Babushkina</surname><given-names>Nadezhda P.</given-names></name></name-alternatives><email>nad.babushkina@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Gomboeva</surname><given-names>Densema E.</given-names></name><name xml:lang="en"><surname>Gomboeva</surname><given-names>Densema E.</given-names></name></name-alternatives><email>gomboeva.densema@medgenetics.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2019</year></pub-date><volume>5</volume><issue>4</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2019/4/НР_БМИ._2019_Том_5__4_Ст._3.pdf" /><abstract xml:lang="ru"><p>Background: Host-pathogenic interaction is a necessary but not sufficient precondition for the development of the disease. The immune response to the introduction of pathogen is largely controlled by genetic factors, whose study is relevant because infectious diseases, such as tuberculosis (TB) and chronic viral hepatitis C (HCV) are highly prevalent in the world. The aim of the study: To study the associations of polymorphic variants of the IL10 (rs1800872) and CXCL10 (rs4386624, rs4256246) genes of the anti-infectious immune response in the development of infectious diseases of various etiologies. Materials and methods: Genotyping was performed in patients with pulmonary tuberculosis (n = 304), viral hepatitis C (n = 184) and relatively healthy individuals (n = 255) by real-time PCR using TaqMan probes and restriction analysis. The associations were evaluated using the &amp;chi;2 test or the Fisher&amp;#39;s exact test. The significance threshold was set at p&amp;lt;0.05. Results: The polymorphism of genes IL10 (rs1800872) and CXCL10 (rs4256264) is associated with infectious diseases of various etiologies. The &amp;ldquo;AC&amp;rdquo; and &amp;ldquo;AA&amp;rdquo; genotypes of the IL10 gene (rs1800872) are &amp;ldquo;adverse&amp;rdquo; to the induction of the immune response to the effects of mycobacterium tuberculosis and the hepatitis C virus. The frequency of these genotypes is higher in patients (HCV &amp;ndash; 43.1%, p = 0.033; TB &amp;ndash; 44.0% p = 0.013) compared with the control (32.2%). The &amp;ldquo;AG&amp;rdquo; and &amp;ldquo;GG&amp;rdquo; genotypes of the CXCL10 gene (rs4256264) are also associated with infectious diseases and are more common in the patients (HCV &amp;ndash; 100%, p = 0.0079; TB &amp;ndash; 99.3%, p = 0.023) compared with control (96.2%). Conclusion: Functionally significant polymorphisms in the IL10 (rs1800872) and CXCL10 (rs4256264) genes are promising prognostic markers of deficiency of the immune response to infection of bacterial and viral etiology.</p></abstract><trans-abstract xml:lang="en"><p>Background: Host-pathogenic interaction is a necessary but not sufficient precondition for the development of the disease. The immune response to the introduction of pathogen is largely controlled by genetic factors, whose study is relevant because infectious diseases, such as tuberculosis (TB) and chronic viral hepatitis C (HCV) are highly prevalent in the world. The aim of the study: To study the associations of polymorphic variants of the IL10 (rs1800872) and CXCL10 (rs4386624, rs4256246) genes of the anti-infectious immune response in the development of infectious diseases of various etiologies. Materials and methods: Genotyping was performed in patients with pulmonary tuberculosis (n = 304), viral hepatitis C (n = 184) and relatively healthy individuals (n = 255) by real-time PCR using TaqMan probes and restriction analysis. The associations were evaluated using the &amp;chi;2 test or the Fisher&amp;#39;s exact test. The significance threshold was set at p&amp;lt;0.05. Results: The polymorphism of genes IL10 (rs1800872) and CXCL10 (rs4256264) is associated with infectious diseases of various etiologies. The &amp;ldquo;AC&amp;rdquo; and &amp;ldquo;AA&amp;rdquo; genotypes of the IL10 gene (rs1800872) are &amp;ldquo;adverse&amp;rdquo; to the induction of the immune response to the effects of mycobacterium tuberculosis and the hepatitis C virus. The frequency of these genotypes is higher in patients (HCV &amp;ndash; 43.1%, p = 0.033; TB &amp;ndash; 44.0% p = 0.013) compared with the control (32.2%). The &amp;ldquo;AG&amp;rdquo; and &amp;ldquo;GG&amp;rdquo; genotypes of the CXCL10 gene (rs4256264) are also associated with infectious diseases and are more common in the patients (HCV &amp;ndash; 100%, p = 0.0079; TB &amp;ndash; 99.3%, p = 0.023) compared with control (96.2%). Conclusion: Functionally significant polymorphisms in the IL10 (rs1800872) and CXCL10 (rs4256264) genes are promising prognostic markers of deficiency of the immune response to infection of bacterial and viral etiology.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>tuberculosis</kwd><kwd>viral hepatitis С</kwd><kwd>genes polymorphism</kwd><kwd>IL10</kwd><kwd>CXCL10</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tuberculosis</kwd><kwd>viral hepatitis С</kwd><kwd>genes polymorphism</kwd><kwd>IL10</kwd><kwd>CXCL10</kwd></kwd-group></article-meta></front><back><ack><p>The work was carried out as part of the implementation of the State task of the Ministry of Science and Higher Education N 075-00603-19-00 (Research Institute of Medical Genetics, Tomsk National Research Center).</p></ack><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Mezentseva VA, Stakhanov MV, Zakharova MV. [Cytokines as markers of the development of infiltrative pulmonary tuberculosis]. Infektsiya i immunitet 2011;1(4):367-372. Russian.</mixed-citation></ref><ref id="B2"><mixed-citation>Moreira-Teixeira L, Redford PS, Stavropoulos E, et al. T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection. J Immunol. 2017;199(2):613-623. DOI: 10.4049/jimmunol.1601340</mixed-citation></ref><ref id="B3"><mixed-citation>Sghaier I, Mouelhi L, Rabia NA, et al. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients. Cytokine. 2017;89:62-67. DOI: 10.1016/j.cyto.2016.10.004</mixed-citation></ref><ref id="B4"><mixed-citation>Chalin A, Lefevre B, Devisme C, et al. Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection. Cytokine. 2019;117:72-78. DOI: 10.1016/j.cyto.2019.02.006</mixed-citation></ref><ref id="B5"><mixed-citation>Bhattacharyya C, Majumder PP, Pandit B. CXCL10 is overexpressed in active tuberculosis patients compared to M. tuberculosis-exposed household contacts. Tuberculosis (Edinb). 2018;109:8-16. DOI: 10.1016/j.tube.2018.01.005</mixed-citation></ref><ref id="B6"><mixed-citation>Bragina EY, Freidin MB, Babushkina NP, et al. Analysis of cytokine network`s genes in the development of &amp;laquo;inverse&amp;raquo; comorbidity between asthma and tuberculosis. Medicinskaya Genetika. 2017;16(1):20-24. Russian.</mixed-citation></ref><ref id="B7"><mixed-citation>Hedrich CM, Bream JH. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res. 2010;47(1-3):185-206. DOI: 10.1007/s12026-009-8150-5</mixed-citation></ref><ref id="B8"><mixed-citation>Swiątek BJ. Is interleukin-10 gene polymorphism a predictive marker in HCV infection? Cytokine Growth Factor Rev. 2012;23(1-2):47-59. DOI: 10.1016/j.cytogfr.2012.01.005</mixed-citation></ref><ref id="B9"><mixed-citation>Wilson JN, Rockett K, Keating B, et al. A hallmark of balancing selection is present at the promoter region of interleukin 10. Genes Immun. 2006;7(8):680-3. DOI: 10.1038/sj.gene.6364336</mixed-citation></ref><ref id="B10"><mixed-citation>Anaya JM, Correa PA, Herrera M, et al. Interleukin 10 (IL-10) influences autoimmune response in primary Sj&amp;ouml;gren&amp;#39;s syndrome and is linked to IL-10 gene polymorphism. J Rheumatol. 2002;29(9):1874-6.</mixed-citation></ref><ref id="B11"><mixed-citation>Lyon H, Lange C, Lake S, et al. IL10 gene polymorphisms are associated with asthma phenotypes in children. Genet Epidemiol. 2004;26(2):155-65. DOI: https://doi.org/10.1002/gepi.10298</mixed-citation></ref><ref id="B12"><mixed-citation>Ke Z, Yuan L, Ma J, et al. IL-10 Polymorphisms and Tuberculosis Susceptibility: An Updated Meta-Analysis. Yonsei Med J. 2015;56(5):1274-1287. DOI: https://doi.org/10.3349/ymj.2015.56.5.1274</mixed-citation></ref><ref id="B13"><mixed-citation>Areeshi MY, Mandal RK, Dar SA, et al.IL-10 -1082 A&amp;gt;G (rs1800896) polymorphism confers susceptibility to pulmonary tuberculosis in Caucasians but not in Asians and Africans: a meta-analysis.Bioscience Reports. 2017;37(5) BSR20170240 DOI: https://doi.org/10.1042/BSR20170240</mixed-citation></ref><ref id="B14"><mixed-citation>Zhang LZ, Zhang TC, Pan FM, et al. Interleukin-10 gene polymorphisms in association with susceptibility to chronic hepatitis C virus infection: a meta-analysis study. Arch Virol. 2010 Nov;155(11):1839-42. DOI: 10.1007/s00705-010-0757-2</mixed-citation></ref><ref id="B15"><mixed-citation>P&amp;aacute;r A, P&amp;aacute;r G, Tornai I, et al. IL28B and IL10R -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort. BMC Res Notes. 2014;7:12. DOI: 10.1186/1756-0500-7-12</mixed-citation></ref><ref id="B16"><mixed-citation>El-Karaksy HM, Sharaf SA, Mandour IA, et al. Effect of interleukin-10 gene promoter polymorphisms -1082 G/A and -592 C/A on response to therapy in children and adolescents with chronic hepatitis C virus infection. Hum Immunol. 2016;77(12):1248-1253. DOI: 10.1016/j.humimm.2016.09.005</mixed-citation></ref><ref id="B17"><mixed-citation>Sheneef A, Esmat MM, Mohammad AN, et al. Noureldin AK5 Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk. J Interferon Cytokine Res. 2017;37(4):175-180. DOI: 10.1089/jir.2016.0106</mixed-citation></ref><ref id="B18"><mixed-citation>Maurya G, Hazam RK. Ruttala R, et al. A study of association between regulatory polymorphism in the IL-10 gene promoter region and acute viral hepatitis, and acute liver failure. Indian J Gastroenterol. 2018;37(4):293-298. DOI: 10.1007/s12664-018-0858-5</mixed-citation></ref><ref id="B19"><mixed-citation>Talaat RM, Dondeti MF, El-Shenawy SZ, et al. Association between IL-10 gene promoter polymorphism and hepatitis B viral infection in an Egyptian population. Biochem Genet. 2014;52(9-10):387-402. DOI: 10.1007/s10528-014-9655-8</mixed-citation></ref><ref id="B20"><mixed-citation>Cunha LRD, Vieira DA, Giampietro YG, et al. Interleukin-10 promoter gene polymorphisms are associated with the first major depressive episode in chronic hepatitis C patients. Clin Res Hepatol Gastroenterol. 2019;43(4):417-426. DOI: 10.1016/j.clinre.2018.11.015</mixed-citation></ref><ref id="B21"><mixed-citation>Blauenfeldt T, Petrone L, Del Nonno F, et al. Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions. Front Immunol. 2018;9:1456. DOI: https://doi.org/10.3389/fimmu.2018.01456</mixed-citation></ref><ref id="B22"><mixed-citation>Ferrari SM, Fallahi P, Ruffilli I, et al. Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C? J Immunol Res. 2019;2019:5878960. DOI: 10.1155/2019/5878960</mixed-citation></ref><ref id="B23"><mixed-citation>Crisan D, Grigorescu MD, Radu C, et al. Interferon-&amp;gamma;-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features &amp;amp; sustained virological response. Indian J Med Res. 2017;145(4):543-550. DOI: 10.4103/ijmr.IJMR_1410_14</mixed-citation></ref><ref id="B24"><mixed-citation>Wang X, Wang S, Liu ZH, et al. Regulatory polymorphism of CXCL10 rs1439490 in seronegative occult hepatitis C virus infection. World J Gastroenterol. 2018;24(20):2191-2202. DOI: 10.3748/wjg.v24.i20.2191</mixed-citation></ref><ref id="B25"><mixed-citation>Tang NL, Fan HP, Chang KC et al. Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis. Clin Chim Acta. 2009;406(1-2):98-102. DOI: 10.1016/j.cca.2009.06.006</mixed-citation></ref><ref id="B26"><mixed-citation>Rougeot J, Torraca V, Zakrzewska A, et al. RNAseq Profiling of Leukocyte Populations in Zebrafish Larvae Reveals a cxcl11 Chemokine Gene as a Marker of Macrophage Polarization During Mycobacterial Infection. Front Immunol. 2019;10:832. DOI: 10.3389/fimmu.2019.00832</mixed-citation></ref><ref id="B27"><mixed-citation>Rodriguez-Berriguete G, Granata G, Puliyadi R, et al. Nucleoporin 54 contributes to homologous recombination repair and post-replicative DNA Integrity. Nucleic Acids Research, 2018;46(15):7731-7746. DOI: 10.1093/nar/gky569</mixed-citation></ref><ref id="B28"><mixed-citation>Tafforeau L, Chantier T, Pradezynski F, et al. Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network. J Virol. 2011;85(24):13010-8. DOI: 10.1128/JVI.02651-10</mixed-citation></ref><ref id="B29"><mixed-citation>Grahnert A, Friedrich M, Pfister M, et al. Mono-ADP-ribosyltransferases in human monocytes: regulation by lipopolysaccharide. Biochem J. 2002;362(Pt 3):717-23. DOI: 10.1042/0264-6021:3620717</mixed-citation></ref><ref id="B30"><mixed-citation>Balducci E, Micossi LG, Soldaini E, et al. Expression and selective up-regulation of toxin-related mono ADP-ribosyltransferases by pathogen-associated molecular patterns in alveolar epithelial cells. FEBS Lett. 2007;581(22):4199-204. DOI: https://doi.org/10.1016/j.febslet.2007.07.061</mixed-citation></ref></ref-list></back></article>